Rivastigmine Tartrate Capsules — Class II drug recall D-1325-2015
Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2015-08-19, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-1325-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2015-08-03 |
| Classified | 2015-08-11 |
| Reported by FDA | 2015-08-19 |
| Terminated | 2017-03-24 |
| Distributed | Nationwide (US) |
| Quantity | 2,952 bottles |
| Reason classes | specification failure |
| NDC | 55111-0352, 55111-0352-01, 55111-0352-05, 55111-0352-30, 55111-0352-60, 55111-0353, 55111-0353-01, 55111-0353-05, 55111-0353-30, 55111-0353-60, 55111-0354, 55111-0354-01, 55111-0354-05, 55111-0354-30, 55111-0354-60, 55111-0355, 55111-0355-01, 55111-0355-05, 55111-0355-30, 55111-0355-60 |
| Lot numbers | C501342 |
| Expiration dates | 2017-01 |
Product
Rivastigmine Tartrate Capsules, USP 1.5 mg, 60 count bottle, Rx Only, Mfd. By Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-352-60
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1325-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.